USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: COLLABORATIVE DRUG DISCOVERY, INC.
Address: 1633 Bayshore Hwy, Suite 342
BURLINGAME, CA
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $299,996.00 2
SBIR Phase II $1,404,275.00 1
STTR Phase I $404,603.00 2
STTR Phase II $997,178.00 1

Award List:

Identification of novel therapeutics for tuberculosis combining cheminformatics,

Award Year / Program / Phase: 2010 / STTR / Phase I
Agency: HHS
Research Institution: Sri International
Principal Investigator: Sean Ekins – 269-930-0974
Award Amount: $149,382.00
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): This Small Business Technology Transfer Phase I project entitled Identification of novel therapeutics for tuberculosis combining cheminformatics, diverse databases and logic-based pathway analysis describes the development of software that will facilitate new… More

Biocomputation across distributed private datasets to enhance drug discovery

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Barry A. Bunin – 650-219-4153
Award Amount: $149,999.00
Abstract:
DESCRIPTION (provided by applicant): Collaborative Drug Discovery, Inc. (CDD) proposes to create a novel web-based software platform that enables scientists to work together effectively to discover and improve new drug leads, yet with the option not to reveal chemical structures to each other. It… More

Identification of novel therapeutics for tuberculosis combining cheminformatics,

Award Year / Program / Phase: 2012 / STTR / Phase II
Agency: HHS
Research Institution: JOHNS HOPKINS UNIVERSITY
Principal Investigator: Sean Ekins – 269-930-0974
Award Amount: $997,178.00
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): We are witnessing the growing menace of both increasing cases of drug-sensitive and drug-resistant Mycobacterium tuberculosis (Mtb) strains and the challenge to produce the first new tuberculosis (TB) drug in well over40 years. The TB community, having invested… More

Identification and Validation of Targets of Phenotypic High Throughput Screening

Award Year / Program / Phase: 2013 / STTR / Phase I
Agency: HHS
Research Institution: SRI INTERNATIONAL
Principal Investigator: Sean Ekins – 215-687-1320
Award Amount: $255,221.00
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Identification and Validation of Targets of Phenotypic High Throughput Screening Hits for Chagas Disease Project Summary Nearly 10 million people in Latin America are infected with the eukaryotic parasite Trypanosoma cruzi, the causative agent of Chagas disease.… More

Modulation of the Innate Immune System by Fisetin for the Treatment of AD

Award Year / Program / Phase: 2013 / SBIR / Phase I
Agency: HHS
Principal Investigator: Barry A. Bunin – 650-219-4153
Award Amount: $149,997.00
Abstract:
DESCRIPTION (provided by applicant): Collaborative Drug Discovery, Inc. (CDD) proposes to create an innovative software module that will help biologists to quickly and easily encode their plain-text biological assay protocols into formats suitable for computational processing. The software will… More

Biocomputation across distributed private datasets to enhance drug discovery

Award Year / Program / Phase: 2013 / SBIR / Phase II
Agency: HHS
Principal Investigator: Sean Ekins – 215-687-1320
Award Amount: $1,404,275.00
Abstract:
DESCRIPTION: Collaborative Drug Discovery, Inc. (CDD) will create a novel web-based software platform that enables scientists to work together effectively to discover and improve new drug leads by sharing computational predictions based on open-source descriptors and models, for the first time… More